Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · IEX Real-Time Price · USD
1.010
-0.040 (-3.81%)
At close: Jun 18, 2024, 4:00 PM
1.020
+0.010 (0.99%)
After-hours: Jun 18, 2024, 7:58 PM EDT

Akebia Therapeutics Revenue

Akebia Therapeutics had revenue of $187.23M in the twelve months ending March 31, 2024, down -30.88% year-over-year. Revenue in the quarter ending March 31, 2024 was $32.61M, a -18.49% decrease year-over-year. In the year 2023, Akebia Therapeutics had annual revenue of $194.62M, a decrease of -33.46%.

Revenue (ttm)
$187.23M
Revenue Growth
-30.88%
P/S Ratio
1.13
Revenue / Employee
$1,121,108
Employees
167
Market Cap
211.69M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023194.62M-97.86M-33.46%
Dec 31, 2022292.48M80.83M38.19%
Dec 31, 2021211.65M-82.99M-28.17%
Dec 31, 2020294.64M-40.36M-12.05%
Dec 31, 2019335.00M127.26M61.26%
Dec 31, 2018207.74M26.52M14.63%
Dec 31, 2017181.23M179.69M11,706.32%
Dec 31, 20161.54M--
Dec 31, 20150--
Dec 31, 20140--
Dec 28, 20130--
Dec 31, 20120--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.